Intriguingly, MCR activation in APP/PS1 mice led to the drastic reduction of the neurotoxic A1 subtype of reactive astrocytes, which is the major astrocytic subtype that mediates astrocytic toxicity in AD. Here, APP is linked to Alzheimer disease.